Society guideline links: Hepatitis C virus infection

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Hepatocellular carcinoma" and "Society guideline links: Hepatitis C infection in solid organ transplant candidates and recipients".)

International

●World Health Organization (WHO): Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection (2018)

●WHO: Guidelines on hepatitis B and C testing (2017)

●World Gastroenterology Organisation (WGO): Practice guideline on hepatitis C (2017)

●WGO: Practice guideline for the management of acute viral hepatitis (2003)

Canada

●Choosing Wisely Canada: Don't repeat hepatitis C viral load testing in an individual who has established chronic infection, outside of antiviral treatment (2022)

●Canadian Paediatric Society (CPS): Position statement for the management of infants, children, and youth at risk for hepatitis C virus (HCV) infection (2021)

●CPS: Position statement on needle stick injuries in the community (2018, updated 2020)

●North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN): Position paper on hepatitis C in 2020 (2020)

●Society of Obstetricians and Gynaecologists of Canada (SOGC): Clinical practice guideline on intrauterine fetal diagnostic testing in women with chronic viral infections (2020)

●Canadian Association for the Study of the Liver (CASL): Guideline on the management of chronic hepatitis C, update (2018)

●Canadian Task Force on Preventive Health Care: Recommendations on hepatitis C screening for adults (2017)

United States

●American Association for the Study of Liver Diseases (AASLD) and Infectious Diseases Society of America (IDSA): HCV guidelines

●AASLD-IDSA: Hepatitis C guidance – Recommendations for testing, managing, and treating hepatitis C virus infection, update (2023)

●Centers for Disease Control and Prevention (CDC): Recommendations for hepatitis C testing among perinatally exposed infants and children – United States (2023)

●CDC: Recommendations for hepatitis C screening among adults – United States (2020)

●North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN): Position paper on hepatitis C in 2020 (2020)

●US Preventive Services Task Force (USPSTF): Final recommendation statement on hepatitis C virus infection in adolescents and adults – Screening (2020)

●American Gastroenterological Association (AGA): Clinical practice update for the care of patients who have achieved a sustained virologic response after antiviral therapy for chronic hepatitis C infection – Expert review (2017)

●AGA: Hepatitis C virus infection care pathway (2017)

Europe

●European Treatment Network For HIV, Hepatitis and Global Infectious Diseases (NEAT-ID): Consensus panel recommendations on recently acquired and early chronic hepatitis C in MSM (2020)

●European Association for the Study of the Liver (EASL): Recommendations on the treatment of hepatitis C (2018)

●European Centre for Disease Prevention and Control (ECDC): Public health guidance on prevention and control of blood-borne viruses in prison settings (2018)

●European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN): A position paper for treatment of chronic hepatitis C virus infection in children (2018)

United Kingdom

●National Institute for Health and Care Excellence (NICE): Public health guideline on hepatitis B and C testing – People at risk of infection (2012, updated 2013)

●Scottish Intercollegiate Guidelines Network (SIGN): National clinical guideline on the management of hepatitis C (2013)

India

●Asian Pacific Association for the Study of the Liver (APASL): Consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing (2016)

Australia–New Zealand

●Australasian Sexual Health Alliance (ASHA): Australian STI management guidelines for use in primary care – Hepatitis C

●Asian Pacific Association for the Study of the Liver (APASL): Consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing (2016)

Japan

●[In English] Japan Pediatric Society (JPS): Clinical practice guidelines for the management of children with mother-to-child transmitted hepatitis C virus infection (2022)

●[In English] Japan Society of Hepatology (JSH): Guidelines for the management of hepatitis C virus infection, 2019 update (published 2020)

●[In Japanese] JSH: Hepatitis C treatment guidelines (2019)

●[In English] Asian Pacific Association for the Study of the Liver (APASL): Consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing (2016)

●[In English] JSH: Guidelines for the management of hepatitis C virus infection – An update for genotype 1 (2014)

●[In English] Japanese Society for Dialysis Therapy (JSDT): Guidelines for treatment of hepatitis C virus type in dialysis patients (2011)

●[In Japanese] JSDT: Guidelines for treatment of hepatitis C virus type in dialysis patients (2011)